BioSpace News Archive

Business

Certara Reports Second Quarter 2023 Financial Results

Certara, Inc., a global leader in biosimulation, reported its financial results for the second quarter of fiscal year 2023.

August 9, 2023
·
24 min read
Business

Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress

Scholar Rock reported financial results and corporate updates for the second quarter ended June 30, 2023.

August 9, 2023
·
10 min read
Business

Repare Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results

Repare Therapeutics Inc., a leading clinical-stage precision oncology company, reported financial results for the second quarter ended June 30, 2023.

August 9, 2023
·
16 min read
Business

Edesa Biotech Reports Fiscal Third Quarter 2023 Results

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, reported financial results for the three and nine months ended June 30, 2023 and provided an update on its business.

August 9, 2023
·
11 min read
Business

Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates

Adicet Bio, Inc., a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, reported financial results and operational highlights for the second quarter ended June 30, 2023.

August 9, 2023
·
10 min read
Business

Ginkgo Bioworks Reports Second Quarter 2023 Financial Results

Ginkgo Bioworks Holdings, Inc., which is building the leading platform for cell programming and biosecurity, announced its results for the second quarter ended June 30, 2023.

August 9, 2023
·
21 min read
Business

Akumin Announces Second Quarter 2023 Results, Revised FY23 Financial Outlook and Establishment of Special Committee

Akumin Inc., a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs, announced its financial results for the quarter ended June 30, 2023.

August 9, 2023
·
14 min read
Business

Immunis Chairman Dr. Hans Keirstead to Speak at the Ending Age-Related Diseases Summit

Immunis, Inc., a private biotechnology company pioneering cellular secretome therapies for age and disease-related immune decline, is excited to announce that its Chairman, Dr. Hans Keirstead, will be a panelist at Lifespan.io’s Ending Age-Related Diseases Summit.

August 9, 2023
·
2 min read
Biotech Bay

Astellas to Open New Life Sciences Facility in DivcoWest’s Cambridge Crossing Neighborhood

Astellas Pharma Inc. and DivcoWest, a DivCore Capital Company, announced plans for Astellas to open a new state-of-the-art life sciences facility at 441 Morgan Avenue, in the Cambridge Crossing neighborhood in Cambridge, Mass.

August 9, 2023
·
6 min read
Genetown

Merus Announces Pricing of Public Offering of Common Shares - August 10, 2023

Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced the pricing of an underwritten public offering of 6,818,182 common shares, at a public offering price of $22.00 per share.

August 9, 2023
·
10 min read